October 3, 2017

Seres’ SER-287 for UC Shows Positive Results in Phase 1b Trial

News

Seres Therapeutics announced positive topline results from the company’s Phase 1b placebo-controlled study investigating the effects of SER-287, a potential microbiome therapy, in patients with ulcerative colitis (UC) who failed ... Read more

August 11, 2017August 16, 2017

Ulcerative Colitis Investigational Therapy TD-1473 Shows Encouraging Results in Early Trial

News, Ulcerative colitis

Early data from a Phase 1b clinical trial show that the investigational therapy TD-1473 for patients with ulcerative colitis (UC) has demonstrated targeted action and effectiveness, according to the therapy’s ... Read more